How to Get Fosamax (Alendronate) in Washington State

What Is Alendronate and Why Washington Patients Use It

Alendronate is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption, approved by the FDA for the treatment and prevention of osteoporosis in postmenopausal women and for glucocorticoid-induced osteoporosis in men and women [1]. The 70 mg once-weekly oral tablet is the most prescribed formulation. An oral solution (70 mg/75 mL) is also available for patients who cannot swallow tablets.

Osteoporosis affects approximately 10.2 million adults in the United States, with an additional 43.4 million having low bone mass, according to the National Osteoporosis Foundation data cited by the CDC [2]. Washington State mirrors national prevalence: among women over 65, hip-fracture hospitalization rates tracked by the Washington State Department of Health consistently exceed 300 per 100,000 person-years.

The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027), demonstrated that alendronate 5 mg/day (later 10 mg/day) reduced clinical vertebral fractures by 55% and hip fractures by 47% over 36 months versus placebo (P<0.001) [3]. That trial remains the foundational evidence base for bisphosphonate prescribing in clinical guidelines, including those of the American Association of Clinical Endocrinology (AACE) [4].

Alendronate's generic form costs as little as $4 to $15 per month at Washington retail chains under GoodRx or Washington Apple Health (Medicaid) pricing, making it one of the most accessible bone-protective agents available.

Who Can Prescribe Fosamax in Washington

Any licensed prescriber in Washington may write an alendronate prescription, including physicians (MD, DO), nurse practitioners (ARNP), and physician assistants (PA-C) [5]. Washington ARNPs practice under full independent authority following passage of ESHB 1881 in 2023, meaning they may prescribe alendronate without a collaborative agreement with a physician [6].

PA-Cs in Washington practice under physician supervision but hold prescriptive authority for Schedule II through V controlled substances and all non-controlled drugs, which includes alendronate [7].

Telehealth providers licensed in Washington may prescribe alendronate as long as the provider holds an active Washington State license, conducts a clinically appropriate evaluation (synchronous video or audio, or asynchronous with supporting DEXA documentation), and complies with WAC 246-919-605 governing telemedicine prescribing [8]. Washington does not require an in-person visit prior to prescribing alendronate via telehealth.

Dentists and optometrists do not hold prescriptive authority for systemic bisphosphonates in Washington.

Labs and Diagnostic Tests Required Before Starting Alendronate

Before writing an alendronate prescription, any prescriber in Washington should confirm that the patient meets both clinical and safety criteria. This requires a defined set of baseline assessments.

Bone mineral density (DEXA scan). DEXA of the lumbar spine and total hip is the standard diagnostic tool. The WHO defines osteoporosis as a T-score of -2.5 or below at either site [9]. The USPSTF recommends DEXA screening for all women aged 65 and older and for younger postmenopausal women whose 10-year fracture risk equals or exceeds that of a 65-year-old white woman, typically estimated using FRAX [10].

Renal function (serum creatinine and eGFR). Alendronate is contraindicated when creatinine clearance falls below 35 mL/min because of inadequate renal clearance and risk of renal toxicity [1]. The FDA label specifies this threshold explicitly.

Serum calcium. Hypocalcemia must be corrected before starting alendronate; the drug may worsen low calcium and precipitate symptomatic tetany. A serum calcium below 8.5 mg/dL warrants supplementation and repeat testing [4].

25-hydroxyvitamin D. AACE guidelines recommend assessing vitamin D status and supplementing to at least 30 ng/mL before and during bisphosphonate therapy [4]. Low vitamin D blunts the drug's ability to increase bone mineral density.

Optional: thyroid-stimulating hormone (TSH) and complete metabolic panel. Secondary causes of bone loss (hyperthyroidism, hyperparathyroidism, malabsorption syndromes) should be excluded in patients with unexpectedly low T-scores, particularly those under age 60 [11].

Washington telehealth platforms typically order labs through LabCorp, Quest Diagnostics, or the patient's existing primary care lab network, with results available within one to three business days. A DEXA scan ordered through a Washington outpatient radiology center is generally completed within seven to 14 business days, depending on region.

How to Get a Fosamax Prescription in Washington: Step-by-Step

Getting alendronate in Washington follows a clear sequence regardless of whether you use an in-person clinic or a telehealth service.

Step 1. Schedule a bone health evaluation. Contact a primary care physician, endocrinologist, rheumatologist, or licensed telehealth provider. Bring any prior DEXA reports and fracture history. If you have not had a DEXA scan, the provider will order one before prescribing.

Step 2. Complete baseline labs. Your provider orders serum creatinine, calcium, and 25-OH vitamin D. If your eGFR returns at 35 mL/min or above, you clear the primary safety threshold for alendronate [1].

Step 3. Receive the prescription. Washington law permits e-prescribing for all non-controlled drugs, so alendronate prescriptions are typically sent electronically to your preferred pharmacy. No paper prescription is required.

Step 4. Choose a pharmacy. Alendronate 70 mg tablets are stocked at most Washington chain pharmacies (Rite Aid, Walgreens, Bartell Drugs, Fred Meyer) and through mail-order services. Washington 503A compounding pharmacies may prepare alendronate in alternative formulations for patients with documented swallowing difficulties or tolerance issues.

Step 5. Address prior authorization if needed. Washington Apple Health (Medicaid) covers alendronate with a prior authorization (PA). Most commercial insurers cover generic alendronate on Tier 1 without PA, but brand-name Fosamax may require step therapy documentation. PA forms typically take two to five business days to process [12].

Step 6. Begin therapy with counseling. Patients must take alendronate with 6 to 8 ounces of plain water, first thing in the morning, 30 minutes before any food, drink, or other medications, and remain upright for at least 30 minutes afterward to reduce esophageal irritation [1].

Telehealth Prescribing of Fosamax in Washington

Washington permits telehealth prescribing of alendronate. The state's telehealth parity law (RCW 48.43.735) requires commercial insurers to cover telehealth services at the same rate as in-person visits, which reduces patient cost barriers for a virtual bone-health consultation [13].

A telehealth provider may prescribe alendronate based on a video or audio consultation when the patient supplies prior DEXA results and recent lab values. If no recent DEXA exists, the provider may order imaging through a Washington radiology network before finalizing the prescription. Asynchronous (store-and-forward) platforms are also permitted under Washington's updated telehealth rules, provided the clinical record contains sufficient diagnostic data [8].

The HealthRX clinical team uses the following decision framework for telehealth alendronate initiation in Washington:

1. Patient uploads DEXA report (T-score -2.5 or below, or -1.0 to -2.4 with FRAX 10-year major osteoporotic fracture risk of 20% or greater per NOF guidelines) [14].
2. Lab panel (creatinine, calcium, 25-OH vitamin D) reviewed by the prescribing clinician.
3. Video consult confirms absence of contraindications: active upper-GI disease, inability to stand or sit upright for 30 minutes, or CrCl <35 mL/min.
4. E-prescription sent to the patient's Washington pharmacy of choice.
5. Follow-up DEXA scheduled at 24 months per AACE monitoring guidance [4].

This framework allows most patients to complete the intake process within two to four business days, assuming labs are drawn promptly.

Telehealth platforms operating in Washington and prescribing bone-health medications include general primary care services and specialty endocrinology consult services. The provider must hold an active Washington medical, ARNP, or PA license; out-of-state licenses without Washington endorsement are not valid for prescribing to Washington residents [5].

Washington Medicaid (Apple Health) Prior Authorization Requirements

Apple Health covers alendronate under the Preferred Drug List, but prescribers must submit a prior authorization request through the ProviderOne portal or via the contracted managed care organization (MCO) when the branded drug or a non-preferred generic is requested [12].

For standard generic alendronate 70 mg weekly, most Apple Health MCOs (Molina Healthcare of Washington, Community Health Plan of Washington, Coordinated Care, United Healthcare Community Plan) list it as a Tier 1 preferred drug with no PA required after September 2023 formulary updates. Prescribers should confirm the current formulary at the time of prescribing, as PDLs update quarterly [12].

When a PA is required, the documentation package typically includes:

• DEXA report with T-score interpretation
• Prescriber attestation of osteoporosis diagnosis (ICD-10: M81.0 for postmenopausal osteoporosis without current pathological fracture)
• Baseline serum creatinine or eGFR confirming CrCl above 35 mL/min
• Vitamin D and calcium levels with notation of supplementation plan if deficient
• For glucocorticoid-induced osteoporosis: documentation of systemic corticosteroid use at prednisone-equivalent 5 mg/day for three or more months

The American Society for Bone and Mineral Research position statement notes that "unnecessary delays in treatment initiation following fragility fracture significantly increase the risk of subsequent fracture," citing a 20% risk of a second fracture within 12 months of the first event [15]. Submitting a complete PA package at the initial request reduces approval time from an average of 10 days to two to three days.

Transferring an Existing Fosamax Prescription to Washington

Patients relocating to Washington with an existing alendronate prescription from another state may transfer the prescription to a Washington pharmacy. Under Washington pharmacy law (WAC 246-869-100), pharmacies may accept transferred prescriptions for non-controlled substances from out-of-state pharmacies [16].

The receiving Washington pharmacist contacts the originating pharmacy to verify the prescription details. If the original prescription has refills remaining, those refills transfer. If refills are exhausted, the new Washington prescriber must issue a fresh prescription.

For patients using mail-order pharmacies based outside Washington, most major mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) are licensed to ship to Washington addresses. Confirm your plan's network before requesting a transfer to avoid a claim denial.

Patients switching to a new Washington-based telehealth or primary care provider should bring their complete medication history and prior DEXA results to the initial consultation. Providers do not need to repeat a DEXA scan if a report dated within 24 months is available and the clinical picture has not changed substantially [4].

503A Compounding Pharmacies and Alendronate in Washington

Washington-licensed 503A compounding pharmacies may prepare alendronate in non-commercially available formulations, such as oral solutions at concentrations other than the branded 70 mg/75 mL product, for patients with a valid patient-specific prescription and a documented clinical need [17].

503A pharmacies operate under both state board of pharmacy oversight (Washington State Board of Pharmacy, RCW 18.64) and federal USP standards. They are distinguished from 503B outsourcing facilities, which produce large batches without patient-specific prescriptions. Alendronate is not on the FDA's list of drugs withdrawn from the market for safety reasons, and it is not a controlled substance, so 503A compounding is legally permissible [17].

Clinically, most patients tolerate the commercially available 70 mg tablet well. The 503A pathway is most relevant for patients with documented esophageal stricture, dysphagia, or severe upper-GI sensitivity who cannot use the standard tablet. A prescriber must document the medical necessity in the prescription.

Washington 503A pharmacies must be licensed by the Washington State Board of Pharmacy. Patients can verify a pharmacy's license at the Washington State Department of Health credential lookup portal.

Monitoring and Follow-Up After Starting Alendronate in Washington

Starting alendronate is not a one-time event. Ongoing monitoring confirms both efficacy and safety.

DEXA at 24 months. AACE 2020 guidelines recommend repeat DEXA two years after initiating bisphosphonate therapy to assess treatment response [4]. A gain of 3% or more in lumbar spine BMD is considered a meaningful treatment response given typical DEXA precision error of 1 to 2% [18].

Serum calcium and vitamin D annually. Annual checks ensure that vitamin D and calcium supplementation remains adequate. The National Institutes of Health recommends 1 to 200 mg elemental calcium daily (from diet plus supplements combined) and 800 to 1 to 000 IU vitamin D daily for postmenopausal women on bisphosphonate therapy [19].

Renal function at 12 months and annually thereafter. Any decline in eGFR below 35 mL/min requires discontinuation. Moderate CKD (eGFR 35 to 60 mL/min) is not an absolute contraindication but warrants closer monitoring [1].

Drug holiday after 3 to 5 years. The FDA communicated guidance in 2012 suggesting that after three to five years of oral bisphosphonate use, clinicians reassess fracture risk; patients at lower risk may pause therapy because of the theoretical risk of atypical femoral fracture with prolonged use [20]. The AACE 2020 update recommends a holiday of one to two years after five years of oral alendronate for patients who have achieved a stable T-score above -2.5 [4].

Atypical femoral fracture surveillance. Patients should report new thigh or groin pain. The FDA label and a 2016 NEJM review (Black DM et al.) estimate the absolute risk of atypical femoral fracture at approximately 3.2 to 50 per 100,000 person-years, increasing with duration of use beyond five years [21].

Osteonecrosis of the jaw (ONJ). ONJ risk with oral alendronate for osteoporosis is estimated at 1 in 10,000 to 1 in 100,000 patient-treatment years, substantially lower than the risk with intravenous bisphosphonates used for oncology indications [22]. Patients should inform their dentist of alendronate use before any invasive dental procedure.

How Long Until You Receive Fosamax in Washington

The timeline from initial contact to first dose depends on the pathway chosen.

For patients with recent DEXA and labs, a telehealth consultation can result in an e-prescription within 24 to 48 hours. Pharmacy dispensing at a Washington retail chain takes one to two business days; mail-order dispensing takes three to five business days.

For patients without prior DEXA, the imaging step adds seven to 14 days depending on radiology scheduling in their Washington region. Urban areas (Seattle, Spokane, Tacoma, Bellevue) generally offer appointments within a week; rural areas may take two to three weeks.

When Apple Health prior authorization is required and the full documentation package is submitted simultaneously with the consultation, approval typically returns within two to three business days under MCO urgent clinical review [12].

The median end-to-end timeline for a new alendronate prescription in Washington, from first telehealth inquiry to medication in hand, is approximately five to ten business days for patients with existing DEXA reports and seven to 21 business days for patients requiring new DEXA imaging.